Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2017 (2017), Article ID 2849801, 10 pages
https://doi.org/10.1155/2017/2849801
Research Article

Preparation and Characterization of Folate-Targeted Fe3O4 Nanoparticle Codelivering Cisplatin and TFPI-2 Plasmid DNA for Nasopharyngeal Carcinoma Therapy

Department of Otorhinolaryngology-Head and Neck Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China

Correspondence should be addressed to Minqiang Xie

Received 14 July 2017; Accepted 13 November 2017; Published 12 December 2017

Academic Editor: Paulo Cesar Morais

Copyright © 2017 Juan Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. C. Yu and J. M. Yuan, “Epidemiology of nasopharyngeal carcinoma,” Seminars in Cancer Biology, vol. 12, no. 6, pp. 421–429, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. M.-X. Zhang, J. Li, G.-P. Shen et al., “Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up,” European Journal of Cancer, vol. 51, no. 17, pp. 2587–2595, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. K. R. Wei, R. S. Zheng, S. W. Zhang, Z. H. Liang, Z. X. Ou, and W. Q. Chen, “Nasopharyngeal carcinoma incidence and mortality in China in,” ChinJCancer, vol. 33, no. 8, pp. 381–387, 2010. View at Google Scholar
  4. X. Sun, S. Su, C. Chen et al., “Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities,” Radiotherapy & Oncology, vol. 110, no. 3, pp. 398–403, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Panyam and V. Labhasetwar, “Biodegradable nanoparticles for drug and gene delivery to cells and tissue,” Advanced Drug Delivery Reviews, vol. 55, no. 3, pp. 329–347, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. I. I. Slowing, J. L. Vivero-Escoto, C. W. Wu, and V. S. Y. Lin, “Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers,” Advanced Drug Delivery Reviews, vol. 60, no. 11, pp. 1278–1288, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. Liu and N. Zhang, “PH-sensitive polymeric micelles for programmable drug and gene delivery,” Current Pharmaceutical Design, vol. 18, no. 23, pp. 3442–3451, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. W. Chen, F. Meng, R. Cheng, C. Deng, J. Feijen, and Z. Zhong, “Advanced drug and gene delivery systems based on functional biodegradable polycarbonates and copolymers,” Journal of Controlled Release, vol. 190, pp. 398–414, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Liu, H. Yu, Y. Sun, M. Zhu, and Y. Duan, “A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery,” Biomaterials, vol. 33, no. 17, pp. 4403–4412, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Zhu, S. Jung, S. Luo et al., “Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers,” Biomaterials, vol. 31, no. 8, pp. 2408–2416, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Costa, A. J. M. Valente, M. G. Miguel, and J. Queiroz, “Plasmid DNA microgels for drug/gene co-delivery: a promising approach for cancer therapy,” Colloids and Surfaces A: Physicochemical and Engineering Aspects, vol. 442, pp. 181–190, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Xie, H. Zhang, Y. Xu et al., “Expression of folate receptors in nasopharyngeal and laryngeal carcinoma and folate receptor-mediated endocytosis by molecular targeted nanomedicine,” International Journal of Nanomedicine, vol. 8, pp. 2443–2451, 2013. View at Google Scholar · View at Scopus
  13. X. M. Z. Hongzheng, “Expression of folate receptor in the tissues and cells of nasopharyngeal carcinoma,” China Journal of Modern Medicine, vol. 19, no. 6, p. 8, 2009. View at Google Scholar
  14. A. Taamma, A. Fandi, N. Azli et al., “Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type,” Cancer, vol. 86, no. 7, pp. 1101–1108, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Izumi, C. Takahashi, J. Oh, and M. Noda, “Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes,” FEBS Letters, vol. 481, no. 1, pp. 31–36, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. W. R. L. Tao and Y. LIU, “Expression of Matrix Metalloproteinase-1(MMP-1) and Tissue Factor Pathway Inhibitor-2(TFPI-2) in Nasopharyngeal Carcinoma and Its significance,” JournalofNanchang University (Mecical Science), vol. 52, no. 7, p. 6, 2012. View at Google Scholar
  17. M. Xie, S. Chen, X. Xu, Z. Li, H. Shen, and J. Xu, “Preparation of two kinds of superparamagnetic carriers-supported cis-platinum complexes and the comparison of their characteristics,” Chinese Science Bulletin, vol. 51, no. 2, pp. 151–157, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Peng, L. Chen, J. Zhang et al., “Induction chemotherapy improved long-term outcomes of patients with locoregionally advanced nasopharyngeal carcinoma: A propensity matched analysis of 5-year survival outcomes in the era of intensity-modulated radiotherapy,” Journal of Cancer, vol. 8, no. 3, pp. 371–377, 2017. View at Publisher · View at Google Scholar · View at Scopus
  19. P. S. Chen, J. L. Su, S. T. Cha et al., “promotes tumor progression by targeting the let-7 microRNA in mice and humans,” miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans, vol. 127, no. 3, pp. 1116–1116, 2017. View at Google Scholar
  20. S. J. An, Y. S. Huang, Z. H. Chen et al., “Lower Ras expression as an independent predictor of patient outcomes in lung cancer treated with bevacizumab plus chemotherapy,” Cancer Gene Therapy, vol. 21, no. 3, pp. 110–114, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Senzer, J. Nemunaitis, D. Nemunaitis et al., “Phase i study of a systemically delivered p53 nanoparticle in advanced solid tumors,” Molecular Therapy, vol. 21, no. 5, pp. 1096–1103, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Liu, W. Xue, B. Ke, M.-Q. Xie, and D. Ma, “Star-shaped cyclodextrin-poly(l-lysine) derivative co-delivering docetaxel and MMP-9 siRNA plasmid in cancer therapy,” Biomaterials, vol. 35, no. 12, pp. 3865–3872, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Liu, X. Wu, Y. Wang et al., “Folate-targeted star-shaped cationic copolymer co-delivering docetaxel and MMP-9 siRNA for nasopharyngeal carcinoma therapy,” Oncotarget , vol. 7, no. 27, pp. 42017–42030, 2016. View at Publisher · View at Google Scholar
  24. S.-J. Sung, S. H. Min, K. Y. Cho et al., “Effect of polyethylene glycol on gene delivery of polyethylenimine,” Biological & Pharmaceutical Bulletin, vol. 26, no. 4, pp. 492–500, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Mitra, U. Gaur, P. C. Ghosh, and A. N. Maitra, “Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier,” Journal of Controlled Release, vol. 74, no. 1–3, pp. 317–323, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Kohori, M. Yokoyama, K. Sakai, and T. Okano, “Process design for efficient and controlled drug incorporation into polymeric micelle carrier systems,” Journal of Controlled Release, vol. 78, no. 1-3, pp. 155–163, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. A. K. Gupta and M. Gupta, “Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications,” Biomaterials, vol. 26, no. 18, pp. 3995–4021, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. C. S. S. R. Kumar and F. Mohammad, “Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery,” Advanced Drug Delivery Reviews, vol. 63, no. 9, pp. 789–808, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Louguet, A. C. Kumar, G. Sigaud, E. Duguet, S. Lecommandoux, and C. Schatz, “A physico-chemical investigation of poly(ethylene oxide)-block-poly(l-lysine) copolymer adsorption onto silica nanoparticles,” Journal of Colloid and Interface Science, vol. 359, no. 2, pp. 413–422, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. Q. He, J. Zhang, J. Shi et al., “The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses,” Biomaterials, vol. 31, no. 6, pp. 1085–1092, 2010. View at Publisher · View at Google Scholar · View at Scopus